Cytoreductive surgery ± hyperthermic intraperitoneal chemotherapy and the value of markers for acute kidney injury.
出版信息
Asian Biomed (Res Rev News). 2024 Dec 16;18(6):244-245. doi: 10.2478/abm-2024-0032. eCollection 2024 Dec.
Abstract
摘要
相似文献
1
Cytoreductive surgery ± hyperthermic intraperitoneal chemotherapy and the value of markers for acute kidney injury.减瘤手术±腹腔热灌注化疗与急性肾损伤标志物的价值
Asian Biomed (Res Rev News). 2024 Dec 16;18(6):244-245. doi: 10.2478/abm-2024-0032. eCollection 2024 Dec.
2
Predictive risk factors of acute kidney injury after cytoreductive surgery and cisplatin-based hyperthermic intra-peritoneal chemotherapy for ovarian peritoneal carcinomatosis.卵巢腹膜癌减瘤手术及顺铂腹腔热灌注化疗后急性肾损伤的预测危险因素
Int J Gynecol Cancer. 2019 Feb;29(2):382-391. doi: 10.1136/ijgc-2018-000099. Epub 2019 Jan 23.
3
Survival and complications of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in elderly patients: a systematic review and meta-analysis.老年患者细胞减灭术和腹腔内热化疗的生存和并发症：系统评价和荟萃分析。
Eur Rev Med Pharmacol Sci. 2021 Sep;25(17):5330-5348. doi: 10.26355/eurrev_202109_26640.
4
Synchronous Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis.同步肝切除、细胞减灭术和腹腔内热灌注化疗治疗结直肠癌肝和腹膜转移：系统评价和荟萃分析。
Dis Colon Rectum. 2021 Jun 1;64(6):754-764. doi: 10.1097/DCR.0000000000002027.
5
Feasibility of radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin.根治性细胞减灭术和腹腔内热灌注化疗治疗阑尾来源的假性黏液瘤腹膜假性黏液瘤的可行性。
Scand J Surg. 2013;102(3):145-51. doi: 10.1177/1457496913490463.
6
Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.细胞减灭术和腹腔内热灌注化疗联合全身化疗与单纯全身化疗治疗结直肠腹膜转移癌的比较。
Cancer. 2010 Aug 15;116(16):3756-62. doi: 10.1002/cncr.25116.
7
Single-Port Laparoscopic Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.单孔腹腔镜减瘤手术联合腹腔热灌注化疗
Am J Case Rep. 2019 Nov 9;20:1648-1651. doi: 10.12659/AJCR.918064.
8
Timing of Systemic Chemotherapy in Patients With Colorectal Peritoneal Carcinomatosis Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.接受细胞减灭术和腹腔内热灌注化疗的结直肠癌腹膜转移患者全身化疗的时机
Dis Colon Rectum. 2017 May;60(5):477-487. doi: 10.1097/DCR.0000000000000774.
9
Anesthesia and pain management of pediatric cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.小儿减瘤手术联合腹腔热灌注化疗的麻醉与疼痛管理
Paediatr Anaesth. 2023 Mar;33(3):193-200. doi: 10.1111/pan.14551. Epub 2022 Sep 8.
10
Abdominal Wall Morbidity Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.减瘤手术及热灌注化疗后腹壁并发症
Scand J Surg. 2017 Dec;106(4):294-298. doi: 10.1177/1457496917690989. Epub 2017 Mar 1.
本文引用的文献
1
Biomarkers in acute kidney injury.急性肾损伤中的生物标志物
Ann Intensive Care. 2024 Sep 15;14(1):145. doi: 10.1186/s13613-024-01360-9.
2
Drug-induced kidney injury: challenges and opportunities.药物性肾损伤：挑战与机遇
Toxicol Res (Camb). 2024 Aug 5;13(4):tfae119. doi: 10.1093/toxres/tfae119. eCollection 2024 Aug.
3
Association of plasma and urine NGAL with acute kidney injury after elective colorectal surgery: A cohort study.择期结直肠手术后血浆和尿液中性粒细胞明胶酶相关脂质运载蛋白与急性肾损伤的关联：一项队列研究
Ann Med Surg (Lond). 2021 Jan 22;62:315-322. doi: 10.1016/j.amsu.2021.01.060. eCollection 2021 Feb.
4
Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced recovery after surgery (ERAS®) Society Recommendations - Part I: Preoperative and intraoperative management.细胞减灭术（CRS）联合或不联合腹腔内热灌注化疗（HIPEC）围手术期护理指南：手术后加速康复（ERAS®）协会推荐 - 第一部分：术前和术中管理。
Eur J Surg Oncol. 2020 Dec;46(12):2292-2310. doi: 10.1016/j.ejso.2020.07.041. Epub 2020 Aug 25.
5
Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced Recovery After Surgery (ERAS®) Society Recommendations - Part II: Postoperative management and special considerations.细胞减灭术 (CRS) 联合或不联合腹腔内热灌注化疗 (HIPEC) 的围手术期护理指南：术后快速康复 (ERAS®) 协会推荐 - 第二部分：术后管理和特殊注意事项。
Eur J Surg Oncol. 2020 Dec;46(12):2311-2323. doi: 10.1016/j.ejso.2020.08.006. Epub 2020 Aug 13.
6
Evaluation of urinary neutrophil gelatinase-associated lipocalin and urinary kidney injury molecule-1 as biomarkers of renal function in cancer patients treated with cisplatin.评价中性粒细胞明胶酶相关脂质运载蛋白和尿肾损伤分子-1 作为顺铂治疗的癌症患者肾功能的生物标志物。
J Oncol Pharm Pract. 2020 Oct;26(7):1643-1649. doi: 10.1177/1078155220901756. Epub 2020 Feb 11.
7
Plasma neutrophil gelatinase-associated lipocalin and factors related to acute kidney injury and mortality in critically ill cancer patients.血浆中性粒细胞明胶酶相关脂质运载蛋白与危重症癌症患者急性肾损伤及死亡率的相关因素
Ecancermedicalscience. 2019 Feb 14;13:903. doi: 10.3332/ecancer.2019.903. eCollection 2019.
8
Biomarkers of Drug-Induced Kidney Toxicity.药物性肾毒性的生物标志物
Ther Drug Monit. 2019 Apr;41(2):213-226. doi: 10.1097/FTD.0000000000000589.
Zotero 插件